[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.41.181. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
April 1987

Prevention of Clot Formation in Cat Retinal Vein by Systemic and Subconjunctival Urokinase

Author Affiliations

From the Departments of Ophthalmology (Drs Levinger and Zauberman and Mr Zelikovitch), Hematology (Dr Eldor), and Pathology (Dr Rosenmann), Hadassah University Hospital and Hebrew University Medical School, Jerusalem.

Arch Ophthalmol. 1987;105(4):554-558. doi:10.1001/archopht.1987.01060040124049
Abstract

• The thrombolytic effect of urokinase was tested on cat retinal vein thrombus induced by argon laser photocoagulation. At various time intervals after thrombosis, intravenous infusion or subconjunctival injections were given. Subconjunctival normal saline injections were used for controls. In vitro subconjunctival urokinase prevented thrombus organization if given within six hours of thrombosis. Subconjunctival injections of urokinase vs normal saline were also studied in vivo in a masked fashion. At intervals of three to 24 hours following thrombosis, 11 cats were treated with subconjunctival urokinase in one eye and normal saline in the 11 fellow eyes. Within ten days after thrombosis, the vein was patent in eight (72%) of the 11 eyes treated with urokinase and in one (9%) of the 11 control eyes.

References
1.
Zauberman H, Levinger S, Burde RM:  Perfusion of occluded retinal vein in the cat's eye . Br J Ophthalmol 1984;68:58-61.Article
2.
Collen D:  On the regulation and control of fibrinolysis: Edward Kowalski Memorial Lecture . Thromb Haemost 1980;43:77-89.
3.
Dacie JV, Lewis SM:  Investigation of the haemorrhagic disorders , in Practical Haematology , ed 4. New York, Churchill Livingstone Inc, 1970, pp 270-273, 277-278.
4.
Gouras P, Hoff M:  Retinal function in an isolated, perfused mammalian eye . Invest Ophthalmol 1970;9:388-399.
5.
Loskutoff DJ, Edgington TE:  Synthesis of a fibrinolytic activator and inhibitor by endothelial cells . Proc Natl Acad Sci USA 1977;74:3903-3907.Article
6.
Howden GD:  The successful treatment of a case of central retinal vein thrombosis with intravenous fibrinolysin . Can Med Assoc J 1959;81:382-384.
7.
Kwaan HC, Dobbie JG, Fetkenhour CL, et al:  Thrombolytic therapy of central retinal vein occlusion , in Martin M, Schoop W, Hirsh J (eds): New Concepts in Streptokinase Dosimetry . Bern, Switzerland, Hans Huber Publishers, 1978, pp 221-229.
8.
Kwaan HC, Dobbie JG, Fetkenhour CL:  Thrombolytic therapy of central retinal vein occlusion: An update , in Mannucci PM, D'Angelo A (eds): Urokinase: Basic and Clinical Aspects . Orlando, Fla, Academic Press Inc, 1982, pp 245-247.
9.
Brancato R, Michelone C:  Subconjunctival urokinase for retinal vein occlusion , in Mannucci PM, D'Angelo A (eds): Urokinase: Basic and Clinical Aspects . Orlando, Fla, Academic Press Inc, 1982, pp 253-258.
10.
Mutlu F:  Experimental retinal vein occlusion and treatment with fibrinolysin . Am J Ophthalmol 1966;62:282-286.
11.
Kohner EM, Hamilton AM, Bulpitt CJ, et al:  Streptokinase in the treatment of central retinal vein occlusion: A controlled trial . Trans Ophthalmol Soc UK 1974;94:599-603.
12.
Verstraete M:  Biochemical and clinical aspects of thrombolysis . Semin Hematol 1978;15:35-54.
13.
Sasahara AA, Sharma GVRK, Tow DE, et al:  Clinical use of thrombolytic agents in venous thromboembolism . Arch Intern Med 1982;142:684-688.Article
14.
Amery A, Delook W, Vermylen J, et al:  Outcome of recent thromboembolic occlusions of limb arteries treated with streptokinase . Br Med J 1970;4:639-644.Article
15.
Markis JE, Malagold M, Parker JA, et al:  Myocardial salvage after intracoronary thrombolysis with streptokinase in acute myocardial infarction . N Engl J Med 1981;305:777-782.Article
16.
Edwards IR, MacLean KS, Dow JD:  Low-dose urokinase in major pulmonary embolism . Lancet 1973;2:409-413.Article
17.
Hess H, Ingrisch H, Mietaschk A, et al:  Local low-dose thrombolytic therapy of peripheral arterial occlusions . N Engl J Med 1982;307:1627-1630.Article
×